2023. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study. Biomolecules and Biomedicine. 23, 6 (Nov. 2023), 1089–1095. DOI:https://doi.org/10.17305/bb.2023.9253.